In addition to being treated with medication for symptoms of an acute flare, should a person with gout be put on long-term uric acid-lowering medication to reduce future flares? And is it safe to keep raising the dose of the medication until uric acid drops below a specified target? Rheumatologists and other physicians are currently grappling with those questions, and a new study may help lead to some answers.
What Is Gout?
Gout is the most common form of inflammatory arthritis in the United States, affecting more than 8 million adults. It develops in some people who have high levels of uric acid in the blood. Needle-shaped crystals form in and around joints – often beginning in the base of the big toe – causing episodes of severe pain, heat and swelling.
Continue reading Increasing Allopurinol Dose May Better Control Gout
A new study found that people with gout have a 25 percent greater likelihood of dying prematurely than people without gout. The findings also show that this increased mortality rate has not improved over the past 16 years, unlike the mortality rate for people with rheumatoid arthritis (RA).
Gout, which affects more than 4 percent of adults in the United States, is the most common form of inflammatory arthritis. It develops in some people who have high levels of uric acid in the blood. The acid can form needle-like crystals in a joint and cause sudden, severe episodes of pain, tenderness, redness, warmth and swelling. Gout is also associated with other illnesses, such as cardiovascular disease and metabolic syndrome.
Continue reading People with Gout at Risk of Premature Death
An international panel of leading gout experts has published new recommendations advising that doctors use a treat-to-target approach for managing gout, a painful form of arthritis that affects more than 8 million adults in the United States. Central to the recommendations is using medication to reduce and keep blood uric acid levels below 6 milligrams per deciliter (mg/dL) – and even lower in people with severe gout. The recommendations were published online in Annals of the Rheumatic Diseases in September.
Continue reading Panel Recommends Aggressive Treat-to-Target Approach to Gout
It may come as a surprise that gout is the most common cause of inflammatory arthritis among adults in the United States.1 It’s also very painful, but gout can be a management disease – meaning there are several things people with gout can do to reduce flares, or eliminate flares all together.
Continue reading Arthritis Foundation Launches Wipe Out Gout – Awareness Campaign
At times, life can be difficult for those living with gout, but it can be just as hard on spouses. When you live in close quarters with a significant other, you undoubtedly feel the pain they deal with on a daily basis. Mira knows this firsthand.
Early on in their marriage, Mira’s husband returned from a business trip with a painful toe and they couldn’t figure out the cause. “For someone who was athletic and never had any health problems, it was inexplicable,” says Mira. “That first attack lasted about a week, and we were young, so he didn’t go see a doctor.”
Continue reading “Honey, I Have Gout”: A Spouse Reflects on Her Worries
Did you know that Gout Awareness Day is held on May 22? In support of Gout Awareness Day today, we’ve launched a new tool to help those that suffer from the disease. Of the nearly 8.3 million adults living with gout, more than half experience multiple gout attacks each year. But having fewer or no gout attacks is possible. The Arthritis Foundation’s Let’s Speak Gout patient tool is now available to empower you to better manage your disease.
Continue reading Let’s Speak Gout: Addressing A Treatable, Yet Often Untreated Condition
“Gout is so 18th century. It’s like, why don’t I get scarlet fever and syphilis as well, while I’m about it?” – Columnist and restaurant critic Giles Coren, The Times, September 13, 2014
That’s just one of hundreds of gout jokes, cartoons and snide jabs that have been spied in the media in the last few years — and that doesn’t take into account a rich tradition of gout lampoonery dating back at least to the 18th century (Google “James Gillray”). Then or now, it’s hard to imagine another disease that gets so little respect. And that’s a problem, according to New Zealand researchers. They say the press perpetuates myths about gout that downplay its seriousness and prevent sufferers from getting treatment.
Continue reading Gout Is No Joke: Misinformation & Shaming May Prevent People from Getting Appropriate Care
Americans of Asian and African descent have much higher risk than white and Hispanic Americans of developing rare but severe, sometimes life-threatening skin reactions to the gout drug allopurinol (Zyloprim), according to a new study published recently in Seminars in Arthritis & Rheumatism.
These two skin reactions, called Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), cause flu-like symptoms, a widespread rash, and large portions of the upper layer of skin (including mucus membranes) to blister and detach. They can also damage other major organs. SJS and TENS, which are believed to be different manifestations of the same disorder, are usually caused by a reaction to a drug (including acetaminophen [Tylenol] and certain antibiotics).
Continue reading Severe Skin Reactions to Gout Drug Allopurinol Linked to Race
As a former football player and wrestler who’d had three knee operations, Scott thought he knew pain. Then he had his first gout attack.
While the pain was new to him, Scott was familiar with gout because his dad had been living with it for 20 years. Gout, a form of inflammatory arthritis, develops in some people who have high levels of uric acid in the blood. The acid can form needle-like crystals in a joint and cause sudden, severe episodes of pain, , (tenderness and redness are not severe – focus on pain, warmth and swelling), warmth and swelling in the joints. For many people, including Scott, the first symptom of gout is excruciating pain and swelling in the big toe. Gout may also appear in another lower-body joint, such as the ankle or knee.
“Basically I described what happened, the doctor looked at my foot, told me I had gout and prescribed some pain medicine,” Scott says. “The pain medicine didn’t do much though. I stopped taking it after a few days and tried to manage around the pain.”
Continue reading Former Football Player Tackles Gout
National Gout Awareness Day is recognized annually on May 22 to help raise awareness around gout, a painful disease that affects approximately 8.3 million Americans.
Gout is a form of inflammatory arthritis that develops as a result of excess levels of uric acid in the blood, which results in a condition called hyperuricemia.. The uric acid can form needle-like crystals in a joint and cause sudden, severe episodes of pain, tenderness, redness, warmth and swelling.
Although gout appears to manifest itself suddenly as an acutely red, hot and swollen joint (often the big toe) with excruciating pain, it’s actually the result of a process that’s been occurring in the body for quite some time. The disease may be chronic for some patients, and for others it may remit for long periods of time, followed by flares for days to weeks.
Continue reading Today is Gout Awareness Day!